Treatment with sclerosant agents
Sclerotherapy is derived from the term “scerolsing” effect, which refers to the inflammatory and fibrotic response produced by the sclerosing agent on the affected tissue. It is a surgical procedure that employs an injection of a chemical solution to irritate and scar the blood vessel lining. This solution causes the blood vessels to constrict, thereby decreasing blood flow to the target area. (1
Sclerotherapy is a common treatment for a variety of conditions, including spider veins, varicose veins, and haemorrhoids. A physician (typically a plastic surgeon) injects a solution into the vein, which causes it to collapse and vanish. The treated area might be a little sore afterward, but it should recover rapidly. STS, or sodium tetradecyl sulphate, is the most prevalent chemical used in sclerotherapy. STS is injected into a vein, causing it to swell and adhere together. This results in the obstructing of blood flow through the vein and its eventual disappearance.
Sclerotherapy is one of the most common procedures performed by dermatologists in the United States, according to the most recent statistics from the American Society for Dermatologic Surgery (ASDS). In 2017, members of the ASDS reported performing nearly 287,000 sclerotherapy procedures, up from 272,000 in 2016. While sclerotherapy can be used to treat a number of vein disorders, spider veins are by far the most common target.
Whether or not a patient is a suitable candidate for sclerotherapy depends on a number of variables. The size and location of the vessels, as well as the patient’s age and medical history, are among these factors. Patients who are pregnant or nursing, as well as those who have recently undergone surgery or who have cancer, are typically not suitable candidates for sclerotherapy. Consultation with a physician is the best method to decide if sclerotherapy is right for you.